Free scoping read. A written assessment of your manuscript in two business days, at no cost.

Start one
Contents

Academy · Research Data, Analytics & AI · Case Report Pain Points

The Clinical Case Report: A Review of the Pain Points, Evidentiary Limits and CARE Reporting Items

A clinical case report cannot establish causation, generalize to other patients or exclude coincidence. A widely cited 2014 methodological review argues that its value lies instead in generating hypotheses and documenting the genuinely unexpected, a role that a 13-item reporting guideline now exists to make reproducible.

Pubrica AcademyWritten by a clinical evidence reviewer Reviewed bya case-report methodology specialist Published10 October 2026 Last checked10 October 2026 Reading time8 minutes Sources10 peer-reviewed

A clinical case report describes an unusual presentation, an unexpected treatment response, or a novel complication in one or a small number of patients, and its specific evidentiary limits are the same limits that make it useful when its claims are appropriately scoped. Nissen and Wynn's 2014 review in BMC Research Notes sets out the documented merits and limitations of the case report, arguing that a case report is most valuable when it alerts the field to something warranting further investigation and least valuable when it is read, or written, as if it could support a causal or generalizable clinical claim1.

Learning objectives

  • What a case report can and cannot establish evidentially, according to a dedicated methodological review
  • The 13 items the CARE guideline requires, and the specific pain points each one addresses
  • The specific difficulties encountered in writing the discussion section

Common misconceptions

  • “A striking clinical case report, if the description is detailed enough, functions as reasonably strong evidence of causation.” Nissen and Wynn's review is explicit that case reports cannot rule out coincidence, cannot control for confounding, and cannot be generalized to other patients, and that their legitimate evidentiary role is to generate hypotheses for future study, not to establish that a given exposure or treatment caused the observed outcome.

Evidentiary scope of the case report

This dual nature is not a contradiction to be resolved but a design feature to be respected: a case report's small sample size, usually one patient, is precisely what allows it to document a novel finding in rich clinical detail, and precisely what prevents it from supporting the population-level inference that a cohort study or trial is designed to provide. Nissen and Wynn's review states the central limitation of the case report plainly: with one or a few patients and no comparison group, a case report cannot distinguish a causal relationship from coincidence, confounding, or the natural course of the condition it describes1. Its documented merit lies in the opposite direction: because case reports describe specific clinical events as they occurred, they remain one of the few publication formats able to flag a novel adverse event, an unexpected drug interaction, or an unusual disease presentation before enough cases have accumulated for formal study, and much of the history of drug-safety signal detection traces back to clinical observations first published in this way1. Sun's practical guidance for first-time case report authors makes a related point from the perspective of writing: a case report merits publication by being unusual, educational, or unexpected, and a case that merely confirms a well-established pattern of disease presentation and treatment response rarely meets the threshold most journals set for publication as a case report8. The practical difficulty is that these two facts, limited evidentiary power and real hypothesis-generating value, are easily conflated when a case report's title or abstract overstates what the case shows.

The 13 CARE items and the pain point each addresses

The CARE guideline, developed by Gagnier, Kienle, and colleagues through a formal consensus process and published in 2013, sets out 13 items a case report should address, including patient information, a timeline presented as a table or figure, diagnostic assessment with the reasoning and alternative diagnoses considered, and a discussion covering the strengths and limitations of the case's management2. Several items exist specifically because of documented weaknesses in case report writing. The explicit timeline item addresses reports that describe events out of sequence or omit dates entirely, making it difficult for a reader to judge the temporal association between an exposure and an outcome; this weakness is notably common, given that timing is usually central to the clinical question that prompted the report. The diagnostic-reasoning item addresses reports that state a final diagnosis without describing which alternative diagnoses were considered and excluded2. Rison's practical guide for first-time case report authors, aimed specifically at the two journals that commissioned much of the early CARE development work, addresses each item with concrete examples of compliant and non-compliant phrasing, which makes it a useful companion for authors translating the more abstract 13-item checklist into manuscript text7. Riley and colleagues' companion explanation-and-elaboration paper for CARE expands on each item with examples specifically chosen because they illustrate common reporting failures the checklist is designed to prevent3.

Common deficiencies in the discussion section

The evidentiary limitation most often becomes apparent in the discussion section: CARE's own guidance requires the discussion to state the rationale for any conclusions, including relevant causal reasoning, which implicitly requires authors to address, rather than pass over, the alternative explanations that a single-case design cannot exclude2. A discussion that states that a drug “caused” an adverse event, rather than that it was associated with it, without addressing timing, dose-response plausibility, dechallenge/rechallenge information if available, and alternative explanations, exemplifies the overreach against which Nissen and Wynn's review warns. It is also one of the more common reasons an otherwise well-documented case report attracts a skeptical peer-review comment, since the single-patient design cannot by itself support causal language of that strength1. ICMJE's own guidance on manuscript preparation reinforces this from the publication-ethics side, stating that conclusions should be appropriately qualified by the strength of the evidence presented, a general principle that applies with particular force to a design that, by construction, has no comparison group against which to validate a causal claim9. Describing the same finding as “temporally associated with” or “a candidate explanation worth further investigation” keeps the claim within what the design of a case report can support. Where a dechallenge (stopping the suspected agent and observing improvement) or rechallenge (reintroducing it and observing recurrence) was performed, reporting that sequence explicitly strengthens the hypothesis considerably more than narrative causal language alone, since it is one of the few forms of evidence that a single-patient design can contribute to a causal argument. In the absence of that sequence, associative language is the appropriate default, and the case remains useful as a hypothesis-generating signal for future, better-designed studies.

CARE's thirteenth item requires reporting whether the patient gave informed consent for publication, and most biomedical journals following ICMJE recommendations will not proceed with peer review of a case report without that documented consent, which makes this a procedural requirement capable of ending a submission entirely, rather than a stylistic matter24. Authors are frequently surprised that consent is required even for an adult patient with full decision-making capacity and a condition with no obviously sensitive content; the requirement is not limited to particularly stigmatizing diagnoses but applies uniformly, because any sufficiently detailed clinical narrative carries some risk of identification. A related and frequently underestimated difficulty is identifiability: removing a patient's name is not sufficient if enough combined clinical, demographic, and circumstantial detail remains for the patient to be identified by people who know them, which is why consent forms and journal policies for case reports typically require the patient to review and approve the specific text intended for publication, not only a generic authorization. COPE's core practices treat a published case report that identifies a patient without adequate consent as grounds for a subsequent correction or retraction, which makes this one of the few difficulties discussed here that can undo a case report's publication entirely rather than merely weakening its scientific contribution10. Incorporating this check into manuscript preparation from the outset, rather than treating it as a final formality before submission, is the most reliable means of avoiding discovery of the problem only after an editor or reviewer raises it. In practice, the patient, or the patient's legal representative where the patient cannot consent directly, should be asked to read the actual draft manuscript intended for submission rather than a generic release form, so that the consent on file covers the specific clinical details, images, and quotations that will appear in print, and so that any detail to which the patient objects can be removed or generalized before peer review rather than after an editor identifies it.

Key points

Key points

The value of a case report lies in hypothesis generation from a documented, specific clinical event, not in causal or generalizable proof. Most of its recurring pain points (an unclear timeline, an unaddressed alternative diagnosis, overreaching causal language or missing documented consent) correspond directly to specific CARE checklist items designed to prevent them.

Practical application

Practical application

  1. Causal language should be matched to what a single-case design can support. Terms such as ‘associated with’ or ‘a candidate explanation’ should be preferred to ‘caused’ unless timing, dose-response and alternative explanations have been addressed and excluded as far as possible.
  2. An explicit timeline should be constructed before the narrative is drafted. Every relevant date and event should first be set out in a table or figure, in accordance with the CARE timeline item, so that the temporal association is clear to the reader rather than reconstructed from prose.
  3. Patient consent should be secured and documented before submission, not after review begins. Authors should confirm that the patient has reviewed the specific text intended for publication and should check the consent and identifiability requirements of the target journal in advance.

Frequently asked questions

Not on its own. Nissen and Wynn's review is explicit that case reports cannot rule out coincidence or confounding; a case report can raise a plausible hypothesis about causation that merits investigation, but establishing causation requires further comparative study.

Presenting dates and events visually, rather than embedded in prose, makes temporal relationships between an exposure and an outcome easy for a reader to verify directly, addressing a documented common weakness in case report narratives.

Not necessarily. If enough combined clinical, demographic, or circumstantial detail remains, a patient can still be identifiable to people who know them, which is why many journals require the patient to review the specific published text, not just a general consent form.

Many journals that publish case reports require or recommend CARE compliance, but this is set by individual journal policy, so authors should check their target journal's specific instructions for authors.

A case report describes one patient (or occasionally a very small number) in depth; a case series aggregates several similar cases, which can offer slightly stronger, though still limited, evidentiary weight by showing a pattern across more than a single instance.

References

  1. Nissen T, Wynn R. The clinical case report: a review of its merits and limitations. BMC Research Notes. 2014;7:264. read 10 October 2026. View on BMC Research Notes
  2. Gagnier JJ, Kienle G, Altman DG, Moher D, Sox H, Riley D, for the CARE Group. The CARE guidelines: consensus-based clinical case reporting guideline development. BMJ Case Reports. 2013;2013:bcr2013201554. read 10 October 2026. View on BMJ Case Reports
  3. Riley DS, Barber MS, Kienle GS, et al. CARE guidelines for case reports: explanation and elaboration document. Journal of Clinical Epidemiology. 2017;89:218-235. read 10 October 2026. View on Journal of Clinical Epidemiology
  4. International Committee of Medical Journal Editors (ICMJE). Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals: Protection of Research Participants. read 10 October 2026. View on ICMJE.org
  5. Gagnier JJ, Kienle G, Altman DG, et al. The CARE guidelines: consensus-based clinical case reporting guideline development. Journal of Medical Case Reports. 2013;7:223. read 10 October 2026. View on Journal of Medical Case Reports
  6. EQUATOR Network. The CARE reporting guideline for writing clinical case report articles. read 10 October 2026. View on EQUATOR Network
  7. Rison RA. A guide to writing case reports for the Journal of Medical Case Reports and BioMed Central Research Notes. Journal of Medical Case Reports. 2013;7:239. read 10 October 2026. View on Journal of Medical Case Reports
  8. Sun Z. Tips for writing a case report for the novice author. Journal of Medical Imaging and Radiation Sciences. 2013;44(2):88-95. read 10 October 2026. View on Journal of Medical Imaging and Radiation Sciences
  9. International Committee of Medical Journal Editors (ICMJE). Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals: Preparing a Manuscript for Submission. read 10 October 2026. View on ICMJE.org
  10. Committee on Publication Ethics (COPE). Core Practices. read 10 October 2026. View on publicationethics.org

Every source above is a peer-reviewed article, a publisher’s record of one, or a standard issued by the body that owns it. Each carries the date it was last read. Where a standard moves, this article is revised rather than left up with a note.

How to cite this article

Pick your referencing style and copy it. Your university or target journal may vary the punctuation — check its guide if it has one.

Pubrica Academy. (2026, October 10). The Clinical Case Report: A Review of the Pain Points, Evidentiary Limits and CARE Reporting Items. Pubrica. https://pubrica.com/academy/case-reporting/the-clinical-case-report-a-review-of-the-pain-points/

This article is written to be learned from. Cite it if you are referring to what it says; if you are using the evidence behind it, cite the sources listed above instead.

CARE-Aligned Case Report Checklist

This checklist should be completed before a clinical case report is submitted.

[ ] Timeline of all relevant dates and events built as a table or figure
[ ] Diagnostic reasoning section names alternative diagnoses considered and why they were ruled out
[ ] Causal language in the discussion matched to what a single-case design can actually support
[ ] Strengths and limitations of the case's own management addressed explicitly in the discussion
[ ] Documented patient consent for publication obtained and reported per the journal's policy
[ ] Checked the full case description for identifiability risk beyond just removing the patient's name

Pubrica AcademyWritten and maintained by Pubrica’s subject matter experts. Articles are revised when the underlying standards change, and each article states the date on which it was last reviewed.

How Pubrica can help

Pubrica’s case report writing team structures manuscripts against the full CARE checklist, calibrates causal language to the evidentiary limits of the single-case design, and checks consent and identifiability requirements before submission.

Find something else

Search the Pubrica Academy

Access is free and requires no account. Enter a topic, or open the full library to filter by category, sub-topic or resource type.

Alignment of case report language with the evidentiary limits of a single-case design

A scoping assessment is free and takes two business days. It provides a written assessment of what the work requires and which specialist would undertake it.

Get a free quote

Regulations

Check your project against this rule

  1. 1Your work
  2. 2Your details
  3. 3Send
What do you need?

Material you send is held under signed confidentiality, with access limited to the assigned team and encrypted transfer. It is not used to train anything and is not passed to third-party tools. Ask for the agreement before you send anything you would rather cover first.